Question special
Chief Resident

Two additional studies in the Journal (Mehra MR, et al in 11 countries between Asia, Europe, and North America and Mancia G, et al in Lombardy, Italy) published on May 1st corroborate the observation that ACE inhibitor and ARB use is not associated with increased risk of Covid-19 infection, severe infection, nor in-hospital death. Are there discussions of collaborating internationally with your data and/or value in doing so? (Mehra MR, DOI: 10.1056/NEJMoa2007621; Mancia G, DOI: 10.1056/NEJMoa2006923)